<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">Stilbene derivatives displayed antiviral activities against SARS-CoV (Li et al. 
 <xref ref-type="bibr" rid="CR66">2006</xref>). The stilbenoid resveratrol (
 <bold>12</bold>) exists widely in different plants including grape 
 <italic>Vitis vinifera</italic> L., 
 <italic>Polygonum cuspidatum</italic>, and cranberry 
 <italic>Vaccinium macrocarpon</italic> Aiton (Lin et al. 
 <xref ref-type="bibr" rid="CR71">2017</xref>). Resveratrol inhibits various viral infections, including the inhibition of HIV and SARS-CoV replication (Li et al. 
 <xref ref-type="bibr" rid="CR66">2006</xref>). Compound 
 <bold>12</bold> was a potent 
 <italic>in vitro</italic> inhibitor of SARS-CoV (at ≤ 0.5 mg/ml) and MERS-CoV, at ≤ 62.5 μM within 24 h of infection (Li et al. 
 <xref ref-type="bibr" rid="CR66">2006</xref>; Lin et al. 
 <xref ref-type="bibr" rid="CR71">2017</xref>). It was predicted that resveratrol (
 <bold>12</bold>) could be a potential agent against new HCoVs in the near future (Lin et al. 
 <xref ref-type="bibr" rid="CR71">2017</xref>).
</p>
